Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects.
Reproductive disorders of newborn (cryptorchidism, hypospadias) and young adult males (low sperm counts, testicular germ cell cancer) are common and/or increasing in incidence. It has been hypothesized that these disorders may comprise a testicular dysgenesis syndrome (TDS) with a common origin in fetal life. This has been supported by findings in an animal model of TDS involving fetal exposure to n(dibutyl) phthalate, as well as by new clinical studies. Recent advances in understanding from such studies have led to refinement of the TDS hypothesis, highlighting the central role that deficient androgen production/action during fetal testis development, may play in the origin of downstream disorders.
Sharpe
Richard M
RM
MRC Human Reproductive Sciences Unit, Centre for Reproductive Biology, The Queen's Medical Research Institute, Edinburgh, United Kingdom. r.sharpe@hrsu.mrc.ac.uk
Skakkebaek
Niels E
NE
D000728:Androgens / Q000502:physiology*; D000818:Animals; D003456:Cryptorchidism / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D007021:Hypospadias / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D013737:Testis / Q000002:abnormalities*
D000728:Androgens